Phoeinix Therapeutics is a small, start up comapny (c.c. 2000/008195/23) in Cape Town, South Africa.
The owner is Dr Campbell Macfarlane

Dr Macfarlane graduated with a BSc (Hons) in Chemistry from the University of Strathclyde, Glasgow in 1970. He completed a PhD in Biochemistry at the University of Aberdeen in 1974 and a year's post-doc at the Biochemistry Department, Medical School, University of Edinburgh in 1975 before emigrating to South Africa in June, 1975.

Initially he worked under contract in the Department of Chemical Pathology at the Red Cross Children's Hospital in Cape Town for five years. In 1980 he married a South African and took a permanent position at Chemical Pathology at Tygerberg. He remained there until his resignation in September 2006. His research interests at Tygerberg Campus were in gestational diabetes and neonatal and adult obesity and he collaborated in several clinical studies. He has published 30 peer reviewed papers. He was president of the South African Association of Clinical Biochemists from 1994-1998 and is the recipient of the Welcome Diagnostics Award (1991) and the Bayer Health Care Senior Researcher Award (1998)

Since 2006 he has attended several graduate level management and business programmes, been on the organizing committee of several congresses, notably International Stem Cell Congresses in Cape Town in 2005 and 2010, and started his own business, Phoenix Therapeutics. He was the Senior Scientific Advisor for Lazaron Biotechnologies a Cord Blood Stem Cell bank for 5 years. He has shown the importance of adult stem cells in refractory obesity and isolated and expanded stem cells from bone marrow and adipose tissue. He resigned from Lazaron in 2011 and now works full time with his own company, Phoenix Therapeutics.